{{Rsnum
|rsid=11849538
|Gene=TCL1A
|Chromosome=14
|position=95709641
|Orientation=plus
|GMAF=0.2392
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=TCL1A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 83.6 | 16.4 | 0.0
| HCB | 57.8 | 35.6 | 6.7
| JPT | 69.0 | 31.0 | 0.0
| YRI | 38.9 | 37.0 | 24.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 57.8 | 35.6 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20876420
|Title=Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
|OA=1
}}
{{PMID Auto GWAS
|PMID=21172079
|Trait=None
|Title=Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations
|RiskAllele=
|Pval=7E-7
|OR=None
|ORtxt=None
|OA=1
}}
{{PMID Auto
|PMID=25035853
|Title=Genotype, allele and haplotype frequencies of four TCL1A gene polymorphisms associated with musculoskeletal toxicity in the South Indian descent
}}